Fig. 5.

Changes in MBP expression. A: the murine internal capsule brain area studied; B: micrograph shows the expression of MBP in the ND + veh control group; C: ND + Stx2 treatment; D: HF + veh treatment; E: HF + Stx2 treatment; F: HC + veh treatment; G: HC + Stx2 treatment; H: HF + HC + veh treatment; I: HF + HC + Stx2 treatment; J: negative control by omitting primary antibody; K: quantification of MBP expression levels in all treatments. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p < 0.005, n = 5. Scale bar in J applies to all panels.